ImmunoTronics is making a difference.
ImmunoTronics is revolutionizing sepsis diagnostics with fast, accurate, and affordable tests. We save lives by using innovative immunoFET technology and a multi-biomarker approach.
The Future of Sepsis Diagnostics
Our immunoFET technology bridges the world of biology and electronics, enabling rapid and precise analysis of multiple biomarkers simultaneously.
We utilize machine learning to analyze data and create predictive models, resulting in even greater diagnostic accuracy.
Our tests are easy to use, requiring no specialized equipment or trained personnel.
Blood sample collection
Placing the sample on the immunoFET chip
ImmunoFET analysis
Test result
Faster Diagnosis, Better Outcomes, Lower Costs
The ImmunoTronics Team
EU-Funded Projects
ImmunoTronics P.S.A. carries out projects co-funded by the European Union.
European Funds for Eastern Poland 2021–2027 · Startup Platforms for New Ideas (Component IIa)
“Democratisation of medical diagnostics of sepsis: development of a single-use pancreatic stone protein (PSP) biosensor based on a three-dimensional graphene network”
- Project number
- FEPW.01.01-IP.01-0917/25
- Objective
- To develop a single-use biosensor-based test for the detection of pancreatic stone protein (PSP) as part of rapid sepsis diagnostics.
- Project value
- PLN 809,743.02
- EU co-funding
- PLN 599,990.00
European Funds for a Modern Economy · Measure FENG.02.28 Startup Booster Poland
Unicorn Hub Startup Booster — individual acceleration programme (acceleration agreement no. 46/UHSB-A/IV/2026)
- Objective
- To prepare the company to raise an investment round (VC acceleration track): an investment-readiness roadmap, due-diligence preparation, and IP documentation with a first draft patent application.
- Activities
- Organising corporate, financial, technological and IP documentation; preparing investor materials and a data room; a financial model; cooperation with a VC fund; patent-attorney services.
- Target group
- VC investors and stakeholders of the company’s medtech solution.
- Results
- A final investor data room, a fundraising and preliminary due-diligence report, an investment-round plan, and a first draft patent application.
- Project value / EU co-funding
- PLN 129,998.60 (grant, 100% reimbursement of eligible costs)